WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

WUXI BIO Splashes Almost $200M to Buy back 2.252M Shrs http://aastocks.com/en/stocks/analysis/stock-aafn-con/02269/NOW.1152150/all

aktuell WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody https://www.prnewswire.com/news-releases/wuxi-biologics-and-immuneoncia-sign-mou-for-development-and-manufacturing-of-anti-pd-l1cd47-bispecific-antibody-301450916.html ...and ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology company in South Korea, today announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnership in the development and manufacturing of IOH-001, ImmuneOncia's therapeutic bispecific antibody targeting PD-L1 and CD47.   ...

vom 24.12. First Shanghai: Maintain WuXi Biologics (02269) "Buy" rating target price of 108.7 Hong Kong dollars https://m.jrj.com.cn/madapter/hk/2021/12/24103534056842.shtml

Hong Kong stocks move | WuXi AppTec (02359) fell 8%, leading the decline in CXO sector demand side concerns as one of the main reasons for the sell-off https://m.jrj.com.cn/madapter/hk/2021/12/20150934034504.shtml

https://finance.yahoo.com/news/sell-rumor-fails-china-biotech-061006902.html Sell the Rumor Fails in China Biotech Stocks as They Roar Back

Are WuXi Biologics (Cayman) Inc.'s (HKG:2269) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? https://simplywall-st.cdn.ampproject.org/v/s/simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/are-wuxi-biologics-cayman-incs-hkg2269-fundamentals-good-eno-1/amp?amp_js_v=a6&amp_gsa=1&usqp=mq331AQKKAFQArABIIACAw%3D%3D#aoh=16397189517819&referrer=https%3A%2F%2Fwww.google.com&amp_tf=Von%20%251%24s&ampshare=https%3A%2F%2Fsimplywall.st%2Fstocks%2Fhk%2Fpharmaceuticals-biotech%2Fhkg-2269%2Fwuxi-biologics-cayman-shares%2Fnews%2Fare-wuxi-biologics-cayman-incs-hkg2269-fundamentals-good-eno-1

https://finance.sina.cn/hkstock/sckxjfx/2021-12-17/detail-ikyakumx4670485.d.html?from=wap ...On the news, WuXi Biologics announced that on December 16, 2021, the company will issue approximately 453,000 shares under the share option plan and repurchase 7,943,500 shares at a cost of approximately HK$700 million, with a price of HK$86.7-89.4 per share. Hong Kong dollar. ...

Ich hab heute auch leicht nachgekauft

Ist ja eine offizielle Liste. Aber momentan werden die Nerven hier ziemlich auf die Probe gestellt 🤪

Danke für die Infos 🙏 Sollte sich dies bewahrheitet, wäre es zumindest ein kleines Zeichen, dass noch etwas Verstand und logisches Denken bei den regierenden vorhanden ist...

Die neue Unternehmensliste des US-Handelsministeriums umfasst 34 chinesische und Hongkonger Unternehmen und Institutionen https://hk.on.cc/hk/bkn/cnt/finance/20211216/mobile/bkn-20211216221837369-1216_00842_001.html ...Es gibt viele A-Aktien notierte Unternehmen wie Weihe Aerospace Chenguang, aber keine Hongkonger Aktien wie WuXi Biologics ( 02269 ) und ähnliche Unternehmen sind notiert. US-Handelsministerin Gina Raimondo erklärte, dass die USA nicht zulassen können, dass US-Waren, Technologien und Software, die medizinische Wissenschaften und biotechnologische Innovationen unterstützen, für Zwecke umgeleitet werden, die die nationale Sicherheit der USA verletzen.

The list is out that roiled China biotech yesterday. No commercial biotech companies are on there. https://t.co/o1sTwSOmnY

Ich wurde auf folgenden T.weet aufmerksam gemacht und WuXi steht damit nicht auf der Liste: https://twitter.com/bradloncar/status/1471490104413855752?t=mBBP3SWcHWcBzfTyGz7MZw&s=08

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1149986/company-news

Ein relativ langer Artikel, vorwiegend jedoch in Bezug auf die WuXi AppTec. https://m.cn.investing.com/analysis/article-200469449 WuXi AppTec has stopped falling and turbulence, and biomedicine is still a popular track ... It is reported that the Chinese medicine and biological industry in Shenwan's primary industry fell 2.31% yesterday, becoming the industry with the largest decline that day. Affected by a rumor that has not been confirmed by the market (the United States is about to release a new round of physical sanctions list, part of the list points to domestic CXO companies), the pharmaceutical sector fell. Since most of the overseas orders of domestic CXO companies come from U.S. pharmaceutical companies, if the U.S. uses biosafety and technical safety as an excuse to impose commercial sanctions, its actions will bring direct economic losses to domestic biopharmaceutical companies related to U.S. stocks. The news has not been verified by relevant US authorities, but the extreme panic in the market still triggered the late sell-off in the stock market on Wednesday   ....